Maintenance in myeloma patients achieving complete response after upfront therapy: a pooled analysis

被引：0

作者：

Chiara Cerrato

Francesco Di Raimondo

Lorenzo De Paoli

Stefano Spada

Francesca Patriarca

Claudia Crippa

Roberto Mina

Tommasina Guglielmelli

Dina Ben-Yehuda

Daniela Oddolo

Chiara Nozzoli

Emanuele Angelucci

Nicola Cascavilla

Rita Rizzi

Stefano Rocco

Luca Baldini

Elena Ponticelli

Magda Marcatti

Clotilde Cangialosi

Tommaso Caravita

Giulia Benevolo

Roberto Ria

Arnon Nagler

Pellegrino Musto

Paola Tacchetti

Paolo Corradini

Massimo Offidani

Antonio Palumbo

Maria Teresa Petrucci

Mario Boccadoro

Francesca Gay

机构：

[1] University of Torino,Myeloma Unit, Division of Hematology

[2] Azienda-Ospedaliero Universitaria Città della Salute e della Scienza di Torino,UOC Ematologia

[3] Azienda Policlinico-OVE,Division of Hematology, Department of Translational Medicine

[4] University of Catania,Dipartimento di Medicina

[5] University of Eastern Piedmont and Maggiore Hospital,Divisione di Ematologia

[6] Università di Udine,Section of Hematology with Transplantation, Department of Emergency and Organ Transplantation

[7] Spedali Civili Brescia,Department of Oncology and Hemato

[8] Department of Clinical and Biological Sciences,oncology

[9] Hematology Department,U.O. Ematologia e Trapianto di Midollo

[10] Hadassah Medical Center,SC Hematology

[11] SODc Terapie cellulari e medicina trasfusionale AOUC Careggi,Hematology Division, Chaim Sheba Medical Center

[12] IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro,Scientific Direction

[13] Hematology “Casa Sollievo della Sofferenza” Hospital IRCCS,“Seràgnoli” Institute of Hematology, Department of Experimental, Diagnostic and Specialty Medicine

[14] University of Bari Medical School,Department of Oncology and Hematology

[15] UOSC Ematologia con Trapianto - AORN Cardarelli Napoli,Clinica di Ematologia

[16] University of Milan,Hematology

[17] Fondazione IRCCS Cà Granda,undefined

[18] Ospedale Maggiore Policlinico,undefined

[19] IRCCS Ospedale San Raffaele,undefined

[20] Ospedali Riuniti Villa Sofia-Cervello,undefined

[21] Unità Operativa di Ematologia I e UTMO,undefined

[22] UOC Ematologia Ospedale S. Eugenio ASL RM2,undefined

[23] Città della Salute e della Scienza Hospital,undefined

[24] University of Bari “Aldo Moro” Medical School,undefined

[25] Department of Biomedical Science,undefined

[26] Internal Medicine “G. Baccelli”,undefined

[27] Policlinico,undefined

[28] Tel HaShomer,undefined

[29] IRCCS Referral Cancer Center of Basilicata,undefined

[30] Bologna University School of Medicine,undefined

[31] University of Milano,undefined

[32] AOU Ospedali Riuniti di Ancona,undefined

[33] “Sapienza” University of Rome,undefined

[34] Takeda,undefined

来源：

Journal of Cancer Research and Clinical Oncology | 2018年 / 144卷

关键词：

Multiple myeloma (MM); Maintenance therapy; Newly diagnosed; Complete response (CR); Prognosis;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1357 / 1366

页数：9

共 50 条

[1] Maintenance in myeloma patients achieving complete response after upfront therapy: a pooled analysis
Cerrato, Chiara
Di Raimondo, Francesco
De Paoli, Lorenzo
Spada, Stefano
Patriarca, Francesca
Crippa, Claudia
Mina, Roberto
Guglielmelli, Tommasina
Ben-Yehuda, Dina
Oddolo, Daniela
Nozzoli, Chiara
Angelucci, Emanuele
Cascavilla, Nicola
Rizzi, Rita
Rocco, Stefano
Baldini, Luca
Ponticelli, Elena
Marcatti, Magda
Cangialosi, Clotilde
Caravita, Tommaso
Benevolo, Giulia
Ria, Roberto
Nagler, Arnon
Musto, Pellegrino
Tacchetti, Paola
Corradini, Paolo
Offidani, Massimo
Palumbo, Antonio
Petrucci, Maria Teresa
Boccadoro, Mario
Gay, Francesca
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (07) : 1357 - 1366
[2] Significant Survival Improvement with Maintenance in Patients Achieving a Complete Response: Pooled Analysis of 4 Italian Phase III Trials in Newly Diagnosed Multiple Myeloma Patients
Cerrato, Chiara
Gay, Francesca
Petrucci, Maria Teresa
Musto, Pellegrino
Gaidano, Gianluca
Offidani, Massimo
Guglielmelli, Tommasina
Salvini, Marco
Patriarca, Francesca
Ponticelli, Elena
Semenzato, Gianpietro
Di Raimondo, Francesco
Mina, Roberto
Cascavilla, Nicola
Ben Yehuda, Dina
Oddolo, Daniela
Corradini, Paolo
Catalano, Lucio
Di Bartolomeo, Paolo
Hajek, Roman
Spencer, Andrew
Boccadoro, Mario
Palumbo, Antonio
BLOOD, 2015, 126 (23)
[3] ROLE OF HEAVY/LIGHT CHAIN RATIO IN MYELOMA PATIENTS ACHIEVING COMPLETE RESPONSE AFTER FIRST LINE THERAPY
D'auria, F.
La Rocca, F.
Simeon, V.
Statuto, T.
Pietrantuono, G.
D'Arena, G.
Villani, O.
Mansueto, G.
Patriarca, A.
Bitetti, C.
Seneca, E.
Traficante, A.
Musto, P.
HAEMATOLOGICA, 2017, 102 : 516 - 517
[4] ROLE OF HEVYLITE® EVALUATION IN MULTIPLE MYELOMA PATIENTS ACHIEVING COMPLETE RESPONSE AFTER TREATMENT
La Rocca, F.
D'Auria, F.
Statuto, T.
Simeon, V.
Guariglia, R.
Pietrantuono, G.
Villani, O.
Mansueto, G.
D'Arena, G.
Criscuolo, C.
Izzo, T.
Laurenzana, I.
Trino, S.
De Luca, L.
Caivano, A.
Musto, P.
HAEMATOLOGICA, 2015, 100 : 99 - 99
[5] The genetic and genomic background of multiple myeloma patients achieving complete response after induction therapy with bortezomib, thalidomide and dexamethasone (VTD)
Terragna, Carolina
Remondini, Daniel
Martello, Marina
Zamagni, Elena
Pantani, Lucia
Patriarca, Francesca
Pezzi, Annalisa
Levi, Giuseppe
Offidani, Massimo
Proserpio, Ilaria
De Sabbata, Giovanni
Tacchetti, Paola
Cangialosi, Clotilde
Ciambelli, Fabrizio
Vigano, Clara Virginia
Dico, Flores Angela
Santacroce, Barbara
Borsi, Enrica
Brioli, Annamaria
Marzocchi, Giulia
Castellani, Gastone
Martinelli, Giovanni
Palumbo, Antonio
Cavo, Michele
ONCOTARGET, 2016, 7 (09) : 9666 - 9679
[6] Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapy
Moustafa, M. Alhaj
Rajkumar, S. V.
Dispenzieri, A.
Gertz, M. A.
Lacy, M. Q.
Buadi, F. K.
Hwa, Y. L.
Dingli, D.
Kapoor, P.
Hayman, S. R.
Lust, J. A.
Kyle, R. A.
Kumar, S. K.
LEUKEMIA, 2015, 29 (10) : 2033 - 2038
[7] Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapy
M Alhaj Moustafa
S V Rajkumar
A Dispenzieri
M A Gertz
M Q Lacy
F K Buadi
Y L Hwa
D Dingli
P Kapoor
S R Hayman
J A Lust
R A Kyle
S K Kumar
Leukemia, 2015, 29 : 2033 - 2038
[8] UPFRONT OR RESCUE TRANSPLANT IN YOUNG PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: A POOLED ANALYSIS OF 529 PATIENTS
Gay, F.
Magarotto, V.
Spencer, A.
Di Raimondo, F.
Pour, L.
Scudla, V.
Genuardi, M.
Carella, A. M.
Liberati, A. M.
Spada, S.
Evangelista, A.
Omede, P.
Nagler, A.
Zambello, R.
Troia, R.
Rossi, G.
Offidani, M.
Oliva, S.
Malfitano, A.
Ben Yehuda, D.
Patriarca, F.
Salvini, M.
Corradini, P.
Foa, R.
Cascavilla, N.
Pulini, S.
Petrucci, M. T.
Hajek, R.
Boccadoro, M.
Palumbo, A.
HAEMATOLOGICA, 2016, 101 : 3 - 3
[9] Prognostic impact of immunophenotypic complete response in patients with multiple myeloma achieving better than complete response
Fukumoto, Kota
Fujisawa, Manabu
Suehara, Yasuto
Narita, Ken-Taro
Usui, Yoshiaki
Takeuchi, Masami
Matsue, Kosei
LEUKEMIA & LYMPHOMA, 2016, 57 (08) : 1786 - 1792
[10] Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma
SV Rajkumar
R Fonseca
TE Witzig
MA Gertz
PR Greipp
Leukemia, 1999, 13 : 469 - 472

← 1 2 3 4 5 →